Dyne Therapeutics, Inc. Common Stock (DYN) is a publicly traded Healthcare sector company. As of October 27, 2026, DYN trades at $15.50 with a market cap of $2.92B and a P/E ratio of -4.43. DYN moved -1.42% today. Year to date, DYN is -15.03%; over the trailing twelve months it is -8.18%. Its 52-week range spans $6.36 to $27.31. Analyst consensus is strong buy with an average price target of $34.67. Rallies surfaces DYN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
13 analysts cover DYN: 0 strong buy, 12 buy, 0 hold, 1 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $34.67.
| Metric | Value |
|---|---|
| Price | $15.50 |
| Market Cap | $2.92B |
| P/E Ratio | -4.43 |
| EPS | $-3.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.31 |
| 52-Week Low | $6.36 |
| Volume | 16.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-446.21M |
| Gross Margin | 0.00% |
13 analysts cover DYN: 0 strong buy, 12 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.67.